{
  "actions": [
    {
      "acted_at": "2025-06-04T15:08:05-04:00",
      "action_code": "72000",
      "how": "by voice vote",
      "references": [],
      "result": "pass",
      "text": "On agreeing to the Bresnahan amendment (A001) Agreed to by voice vote.",
      "type": "vote",
      "vote_type": "vote",
      "where": "h"
    },
    {
      "acted_at": "2025-06-04T15:05:11-04:00",
      "action_code": "71000",
      "references": [
        {
          "reference": "CR H2453",
          "type": "consideration"
        },
        {
          "reference": "CR H2453",
          "type": "text"
        }
      ],
      "text": "Amendment (A001) offered by Mr. Bresnahan.",
      "type": "action"
    },
    {
      "acted_at": "2025-06-04T15:05:11-04:00",
      "action_code": "71000",
      "references": [],
      "text": "House Amendment Offered",
      "type": "action"
    },
    {
      "acted_at": "2025-06-04T15:08:05-04:00",
      "action_code": "72000",
      "references": [],
      "text": "House amendment agreed to: On agreeing to the Bresnahan amendment (A001) Agreed to by voice vote.",
      "type": "action"
    }
  ],
  "amendment_id": "hamdt23-119",
  "amendment_type": "hamdt",
  "amends_amendment": null,
  "amends_bill": {
    "bill_id": "hr2483-119",
    "bill_type": "hr",
    "congress": 119,
    "number": 2483
  },
  "amends_treaty": null,
  "chamber": "h",
  "congress": "119",
  "description": "An amendment numbered 1 printed in Part A of House Report 119-130 to require all HHS regulations or guidance documentation to use language that is inclusive of all opioid overdose reversal drugs that have been approved by FDA, instead of referring to brand names.",
  "introduced_at": "2025-06-04",
  "number": 23,
  "purpose": null,
  "sponsor": {
    "bioguide_id": "B001327",
    "district": "8",
    "name": "Bresnahan, Robert P.",
    "state": "PA",
    "title": "Rep.",
    "type": "person"
  },
  "status": "pass",
  "status_at": "2025-06-04T15:08:05-04:00",
  "updated_at": "2025-06-05T15:29:32Z"
}